Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases.

Cheng, Peng; Zhang, Fangfang; Yu, Lechu; Lin, Xiufei; He, Luqing; Li, Xiaokun; Lu, Xuemian; Yan, Xiaoqing; Tan, Yi; Zhang, Chi

Cheng, Peng; Zhang, Fangfang; Yu, Lechu; Lin, Xiufei; He, Luqing; Li, Xiaokun; Lu, Xuemian; Yan, Xiaoqing; Tan, Yi; Zhang, Chi.

Afiliação

Cheng P; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; School of Pharm
Zhang F; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; School of Pharm
Yu L; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China.
Lin X; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; School of Pharm
He L; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; School of Pharm
Li X; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Lu X; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China.
Yan X; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; School of Pharm
Tan Y; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; Kosair Children
Zhang C; The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou 325035, China; Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 325200, China; School of Pharm

J Diabetes Res ; 2016: 1540267, 2016.

Article em En | MEDLINE | ID: mdl-27247947

Assuntos

Doenças Cardiovasculares/metabolismo; Cardiomiopatias Diabéticas/metabolismo; Fatores de Crescimento de Fibroblastos/fisiologia; Animais; Fatores de Crescimento de Fibroblastos/farmacologia; Humanos; Estresse Oxidativo/efeitos dos fármacos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Cardiomiopatias Diabéticas / Fatores de Crescimento de Fibroblastos Limite: Animals / Humans Idioma: En Revista: J Diabetes Res Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google